文献速递脊柱外科小儿骨科

骨骼发育不良患者早发性脊柱侧凸完成生长友好型手术治疗后的结局

Outcomes after completing growth-friendly surgical treatment for early-onset scoliosis in patients with skeletal dysplasia.
PubMed 文献 · Bone Joint J · 2024-06-01

本研究回顾性比较骨骼发育不良与其他综合征早发性脊柱侧凸患者完成生长友好型手术治疗后的结局,骨骼发育不良组20例、对照组292例。骨骼发育不良组并发症率更高(1.6倍,95%CI 1.3至2.0),年度脊柱高度增量更少(9.3 mm vs 16 mm,p<0.001),主弯矫正率与生活质量无显著差异。作者认为该治疗应保留给严重、进展性且非手术治疗难治的畸形。

要点

  • 骨骼发育不良组并发症率为其他综合征组的1.6倍(95%CI 1.3至2.0)。
  • 骨骼发育不良组年度脊柱高度增量9.3 mm(SD 5.1)低于对照组16 mm(SD 9.2),p<0.001。
  • 主弯矫正率组间无显著差异(43% vs 28%,p=0.087),生活质量评分无显著差异。

核心结论

  • 骨骼发育不良患者完成生长友好型早发性脊柱侧凸治疗后并发症发生率高于其他综合征患者。
  • 作者认为骨骼发育不良相关早发性脊柱侧凸的手术生长友好型治疗应保留给严重、进展性且对非手术治疗难治的畸形患者。

研究设计与样本

  • 回顾性识别2000年1月1日至2018年12月31日期间完成生长友好型手术治疗的早发性脊柱侧凸患者,骨骼发育不良组20例,其他综合征对照组292例。
  • 比较两组的影像学参数、并发症和健康相关生活质量(HRQoL),骨骼发育不良组平均随访8.6年(SD 3.3),对照组6.6年(SD 2.6)。

主要发现

  • 每例患者平均主弯矫正率骨骼发育不良组43% vs 对照组28%,p=0.087。
  • 年度脊柱高度平均增量骨骼发育不良组9.3 mm(SD 5.1) vs 对照组16 mm(SD 9.2),p<0.001。
  • 撑开期间按患者术前站立身高调整的年度脊柱生长率骨骼发育不良组11% vs 对照组14%,p=0.070。
  • 骨骼发育不良组并发症率为对照组的1.6倍(95%CI 1.3至2.0)。
  • 骨骼发育不良组更常见的并发症包括:神经损伤(率比RR 5.1,95%CI 2.3至11)、深部手术部位感染(RR 2.2,95%CI 1.2至4.1)、植入物相关并发症(RR 2.0,95%CI 1.5至2.7)和计划外翻修(RR 1.8,95%CI 1.3至2.5)。

临床怎么用

  • 作者认为骨骼发育不良相关早发性脊柱侧凸的手术生长友好型治疗应保留给严重、进展性且对非手术治疗难治的畸形患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to compare outcomes after growth-friendly treatment for early-onset scoliosis (EOS) between patients with skeletal dysplasias versus those with other syndromes. METHODS: We retrospectively identified 20 patients with skeletal dysplasias and 292 with other syndromes (control group) who had completed surgical growth-friendly EOS treatment between 1 January 2000 and 31 December 2018. We compared radiological parameters, complications, and health-related quality of life (HRQoL) at mean follow-up of 8.6 years (SD 3.3) in the dysplasia group and 6.6 years (SD 2.6) in the control group. RESULTS: Mean major curve correction per patient did not differ significantly between the dysplasia group (43%) and the control group (28%; p = 0.087). Mean annual spinal height increase was less in the dysplasia group (9.3 mm (SD 5.1) than in the control group (16 mm (SD 9.2); p < 0.001). Mean annual spinal growth adjusted to patient preoperative standing height during the distraction period was 11% in the dysplasia group and 14% in the control group (p = 0.070). The complication rate was 1.6 times higher (95% confidence interval (CI) 1.3 to 2.0) in the dysplasia group. The following complications were more frequent in the dysplasia group: neurological injury (rate ratio (RR) 5.1 (95% CI 2.3 to 11)), deep surgical site infection (RR 2.2 (95% CI 1.2 to 4.1)), implant-related complications (RR 2.0 (95% CI 1.5 to 2.7)), and unplanned revision (RR 1.8 (95% CI 1.3 to 2.5)). Final fusion did not provide additional spinal height compared with watchful waiting (p = 0.054). There were no significant differences in HRQoL scores between the groups. CONCLUSION: After growth-friendly EOS treatment, patients with skeletal dysplasias experienced a higher incidence of complications compared to those with other syndromes. Surgical growth-friendly treatment for skeletal dysplasia-associated EOS should be reserved for patients with severe, progressive deformities that are refractory to nonoperative treatment.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Saarinen AJ, Sponseller P, Thompson GH, et al. Outcomes after completing growth-friendly surgical treatment for early-onset scoliosis in patients with skeletal dysplasia. Bone Joint J. 2024. PMID: 38821501. doi:10.1302/0301-620X.106B6.BJJ-2023-1417.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。